Moluzaq 200mg contains Molnupiravir, an oral antiviral medicine developed to treat mild to moderate COVID-19 in adults at risk of developing severe illness.
| Composition | Molnupiravir |
| Manufacturer | Astraea Life Sciences Pvt Ltd |
| Packing | 40 Capsules |
| Prescribed For | (COVID-19) |
| Expiry | December 2027 |
